ATE78481T1 - Stoff, stoffzusammensetzung und deren anwendungsverfahren. - Google Patents

Stoff, stoffzusammensetzung und deren anwendungsverfahren.

Info

Publication number
ATE78481T1
ATE78481T1 AT85901227T AT85901227T ATE78481T1 AT E78481 T1 ATE78481 T1 AT E78481T1 AT 85901227 T AT85901227 T AT 85901227T AT 85901227 T AT85901227 T AT 85901227T AT E78481 T1 ATE78481 T1 AT E78481T1
Authority
AT
Austria
Prior art keywords
substance
derivs
formula
composition
pancratistatin
Prior art date
Application number
AT85901227T
Other languages
English (en)
Inventor
George R Pettit
Original Assignee
Univ Arizona State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona State filed Critical Univ Arizona State
Application granted granted Critical
Publication of ATE78481T1 publication Critical patent/ATE78481T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
AT85901227T 1984-02-17 1985-02-19 Stoff, stoffzusammensetzung und deren anwendungsverfahren. ATE78481T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/581,188 US4985436A (en) 1984-02-17 1984-02-17 Composition of matter for inhibiting leukemias and sarcomas
PCT/US1985/000237 WO1985003708A1 (en) 1984-02-17 1985-02-19 Substance, composition of matter and method of using same
EP85901227A EP0175709B1 (de) 1984-02-17 1985-02-19 Stoff, stoffzusammensetzung und deren anwendungsverfahren

Publications (1)

Publication Number Publication Date
ATE78481T1 true ATE78481T1 (de) 1992-08-15

Family

ID=24324233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85901227T ATE78481T1 (de) 1984-02-17 1985-02-19 Stoff, stoffzusammensetzung und deren anwendungsverfahren.

Country Status (11)

Country Link
US (2) US4985436A (de)
EP (1) EP0175709B1 (de)
JP (1) JPH0699436B2 (de)
KR (1) KR900004003B1 (de)
AT (1) ATE78481T1 (de)
AU (1) AU571948B2 (de)
CA (1) CA1297108C (de)
DE (1) DE3586381T2 (de)
IT (1) IT1221760B (de)
NO (1) NO854112L (de)
WO (1) WO1985003708A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001140A (en) * 1989-04-17 1991-03-19 Hoffmann-La Roche Inc. Cycloalkylthiazoles
US5180733A (en) * 1990-03-30 1993-01-19 Abbott Laboratories Biogenic amine uptake inhibitors
BR9306042A (pt) * 1992-02-28 1997-11-18 Autoimmune Inc Método para tratar uma doença auto-immune em um mamifero e formas de dosagens farmacêuticas oral e inalável
US5529989A (en) * 1995-01-09 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Pancratistatin prodrug
AU2001238499A1 (en) 2000-02-18 2001-08-27 New York Medical College Nitroacridine/tumor inhibitor compositions
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7314953B2 (en) * 2001-03-27 2008-01-01 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
AU2003243272A1 (en) * 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
US7462609B2 (en) * 2002-12-09 2008-12-09 Arizona Board Of Regents Narcistatin prodrugs
EP1720552A2 (de) * 2004-03-05 2006-11-15 Arizona Board of Regents, acting for and on behalf of Arizona State University Verfahren zur behandlung entzündlicher und autoimmun-erkrankungen
EP1817020A4 (de) * 2004-11-08 2012-11-21 Errant Gene Therapeutics Inc Inhibitoren der histondeacetylase
FR2934266B1 (fr) * 2008-07-28 2010-09-17 Pf Medicament Derives azotes de la pancratistatine
US20180030095A1 (en) 2015-02-13 2018-02-01 George Robert Pettit Silstatin compounds
CN106543194A (zh) * 2015-09-22 2017-03-29 孙青* 水仙环素衍生物及其制备与在制备抗肿瘤药物中的应用
WO2019094709A1 (en) 2017-11-09 2019-05-16 Pettit George R Betulastatin compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3583993A (en) * 1967-03-28 1971-06-08 Shionogi & Co Plant growth regulating substances,lycoricidins
US3588993A (en) * 1969-03-21 1971-06-29 Kay Mfg Corp Apparatus and method for feeding nested coil springs in rows

Also Published As

Publication number Publication date
CA1297108C (en) 1992-03-10
AU571948B2 (en) 1988-04-28
EP0175709A1 (de) 1986-04-02
DE3586381D1 (de) 1992-08-27
US4866071A (en) 1989-09-12
JPS61501986A (ja) 1986-09-11
NO854112L (no) 1985-10-16
AU3997885A (en) 1985-09-10
US4985436A (en) 1991-01-15
DE3586381T2 (de) 1993-01-21
JPH0699436B2 (ja) 1994-12-07
EP0175709A4 (de) 1986-07-24
IT8521938A0 (it) 1985-08-14
EP0175709B1 (de) 1992-07-22
KR900004003B1 (en) 1990-06-07
WO1985003708A1 (en) 1985-08-29
IT1221760B (it) 1990-07-12

Similar Documents

Publication Publication Date Title
ATE78481T1 (de) Stoff, stoffzusammensetzung und deren anwendungsverfahren.
SE8504720D0 (sv) New drug preparation
NO873244D0 (no) Legemiddel.
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
ATA701479A (de) Verfahren zur herstellung von neuen chinolinen, chinoxalinen und chanzolinen und deren pharmazeutisch verwendbaren derivaten
FI880453A7 (fi) Nukutusainekoostumus ja menetelmä sen käyttämiseksi.
ES8604524A1 (es) Procedimiento para preparar 5,11-dihidro-11-((1-metil-4-pi- peridinil)amino)carbonil)-6h-dibenzo(b,e)-azepin-6-ona
DE3579989D1 (de) Mischung von interferon und cyclaradin.
AT372965B (de) Verfahren zur herstellung von neuen 1-oxo-1hpyrimido(6,1-b)benzthiazol-derivaten und von deren salzen
DE3577443D1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
ATE49121T1 (de) Entzuendungshemmende zusammensetzungen und verfahren.
AT346825B (de) Verfahren zur herstellung von neuen 3- aminomethyl-2-phenylbicyclo(2,2,2)octanen und -octenen und deren saeureadditionssalzen
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
ATA163577A (de) Verfahren zur herstellung von neuen 3-aminomethyl-2-phenylbicyclo (2,2,2) octanen und -octenen sowie deren saureadditionssalzen
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos
FI853354A7 (fi) Aminohappojohdokset, menetelmä niiden valmistamiseksi ja farmaseuttiset seokset.
ATA559778A (de) Verfahren zur herstellung von neuen 1,2- -benzisothiazolen und deren saeureadditions- salzen
ATE103899T1 (de) Zwischenprodukte und verfahren zu ihrer herstellung.
DE3785895D1 (de) Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
AT351030B (de) Verfahren zur herstellung von neuen 1,2- dihydro-6-phenyl-1h,4h-imidazo (1,2a) (1,4) benzodiazepin-1-onen sowie von deren saeure- additionssalzen
FR2496466B1 (fr) Production d'hormone lactogene, placentaire, humaine
AT349470B (de) Verfahren zur herstellung von neuen 4,4- diphenylcyclohexylpiperidinderivaten sowie deren pharmazeutisch anwendbaren saeureadditionssalzen
FR2558830B1 (fr) 1-hydroxyvitamines d insaturees en chaine laterale, composition pharmaceutique et procede de preparation
ATA566978A (de) Verfahren zur herstellung von substituierten orotsaeuren, dihydroorotsaeuren und deren salzen
DE3581259D1 (de) Vasodilatationsverbindungen, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.